LGM Pharma Attends CPhI Conference in Germany

BOCA RATON, Florida—LGM Pharma, a supplier of active pharmaceutical ingredients (APIs), recently attended the CPhI Worldwide Conference in Frankfurt, Germany. The conference agenda tackled the most timely and business critical issues facing the pharmaceutical industry today.


According to Mendy Schurder, COO of LGM Pharma, “By attending a CPhI conference, we had the opportunity to gather the latest market trends, explore key case study insights and benefit from exceptional networking opportunities all under one roof.”

During the conference, representatives of LGM Pharma met with strategic manufacturers to discuss involvement in the development of commercial products.

“Now that LGM Pharma has gained a certain reputation, we received positive feedback from manufacturers who were enthusiastic about working with us,” continued Mr. Schurder. “We had a number of successful meetings with clients and brought them key projects. We were delighted with their interest in working with us.”

About LGM Pharma

LGM Pharma is a leading supplier of active pharmaceutical ingredients (APIs) to various global pharmaceutical firms involved in the research and development of old and new therapeutic chemical entities. In its commitment to improving health opportunities all over the world, the company has forged partnerships with some of the biggest names in the pharmaceutical industry. Currently, the company supplies over 2,500 active pharmaceutical ingredients to its global clients. For more information, visit www.lgmpharma.com.

About CPhI Worldwide

CPhI Worldwide is a unique event for the global Pharma community. Exhibitors have been benefiting from its unequalled business and networking opportunities for more than 20 years.

  • Share:

Leave a comment